242 related articles for article (PubMed ID: 25670543)
1. Practical implementation of failure mode and effects analysis for safety and efficiency in stereotactic radiosurgery.
Younge KC; Wang Y; Thompson J; Giovinazzo J; Finlay M; Sankreacha R
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1003-8. PubMed ID: 25670543
[TBL] [Abstract][Full Text] [Related]
2. Failure mode and effects analysis and fault tree analysis of surface image guided cranial radiosurgery.
Manger RP; Paxton AB; Pawlicki T; Kim GY
Med Phys; 2015 May; 42(5):2449-61. PubMed ID: 25979038
[TBL] [Abstract][Full Text] [Related]
3. Failure mode and effects analysis based risk profile assessment for stereotactic radiosurgery programs at three cancer centers in Brazil.
Teixeira FC; de Almeida CE; Saiful Huq M
Med Phys; 2016 Jan; 43(1):171. PubMed ID: 26745909
[TBL] [Abstract][Full Text] [Related]
4. Risk analysis by FMEA as an element of analytical validation.
van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Oldenhof MT; Vredenbregt MJ; Barends DM
J Pharm Biomed Anal; 2009 Dec; 50(5):1085-7. PubMed ID: 19640668
[TBL] [Abstract][Full Text] [Related]
5. Failure modes and effects analysis (FMEA) for Gamma Knife radiosurgery.
Xu AY; Bhatnagar J; Bednarz G; Flickinger J; Arai Y; Vacsulka J; Feng W; Monaco E; Niranjan A; Lunsford LD; Huq MS
J Appl Clin Med Phys; 2017 Nov; 18(6):152-168. PubMed ID: 29082599
[TBL] [Abstract][Full Text] [Related]
6. Validating FMEA output against incident learning data: A study in stereotactic body radiation therapy.
Yang F; Cao N; Young L; Howard J; Logan W; Arbuckle T; Sponseller P; Korssjoen T; Meyer J; Ford E
Med Phys; 2015 Jun; 42(6):2777-85. PubMed ID: 26127030
[TBL] [Abstract][Full Text] [Related]
7. Application of failure mode and effects analysis to intracranial stereotactic radiation surgery by linear accelerator.
Masini L; Donis L; Loi G; Mones E; Molina E; Bolchini C; Krengli M
Pract Radiat Oncol; 2014; 4(6):392-7. PubMed ID: 25407860
[TBL] [Abstract][Full Text] [Related]
8. Failure mode and effects analysis of linac-based liver stereotactic body radiotherapy.
Rusu I; Thomas TO; Roeske JC; Mescioglu I; Melian E; Surucu M
Med Phys; 2020 Mar; 47(3):937-947. PubMed ID: 31837024
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unit.
Bonfant G; Belfanti P; Paternoster G; Gabrielli D; Gaiter AM; Manes M; Molino A; Pellu V; Ponzetti C; Farina M; Nebiolo PE
J Nephrol; 2010; 23(1):111-8. PubMed ID: 20091494
[TBL] [Abstract][Full Text] [Related]
10. Failure mode and effect analysis for delivery of lung stereotactic body radiation therapy.
Perks JR; Stanic S; Stern RL; Henk B; Nelson MS; Harse RD; Mathai M; Purdy JA; Valicenti RK; Siefkin AD; Chen AM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1324-9. PubMed ID: 22197236
[TBL] [Abstract][Full Text] [Related]
11. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators.
Ciocca M; Cantone MC; Veronese I; Cattani F; Pedroli G; Molinelli S; Vitolo V; Orecchia R
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e305-11. PubMed ID: 21708432
[TBL] [Abstract][Full Text] [Related]
12. Failure mode and effects analysis (FMEA) to enhance the safety and efficiency of Gamma Knife radiosurgery.
Warnick RE; Lusk AR; Thaman JJ; Levick EH; Seitz AD
J Radiosurg SBRT; 2020; 7(2):115-125. PubMed ID: 33282465
[TBL] [Abstract][Full Text] [Related]
13. Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT).
Veronese I; De Martin E; Martinotti AS; Fumagalli ML; Vite C; Redaelli I; Malatesta T; Mancosu P; Beltramo G; Fariselli L; Cantone MC
Radiat Oncol; 2015 Jun; 10():132. PubMed ID: 26071401
[TBL] [Abstract][Full Text] [Related]
14. Quality Assurance with Plan Veto: reincarnation of a record and verify system and its potential value.
Noel CE; Gutti V; Bosch W; Mutic S; Ford E; Terezakis S; Santanam L
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1161-6. PubMed ID: 24661669
[TBL] [Abstract][Full Text] [Related]
15. Failure mode and effect analysis in blood transfusion: a proactive tool to reduce risks.
Lu Y; Teng F; Zhou J; Wen A; Bi Y
Transfusion; 2013 Dec; 53(12):3080-7. PubMed ID: 23560475
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal injections: a healthcare failure modes and effects analysis.
Lanzetta P; Holz F; Monés J; Querques G; Stanga P; Veritti D; Barbone F; Brusaferro S; Isola M
Ophthalmologica; 2013; 230(3):151-64. PubMed ID: 24008511
[TBL] [Abstract][Full Text] [Related]
17. Consistency of FMEA used in the validation of analytical procedures.
Oldenhof MT; van Leeuwen JF; Nauta MJ; de Kaste D; Odekerken-Rombouts YM; Vredenbregt MJ; Weda M; Barends DM
J Pharm Biomed Anal; 2011 Feb; 54(3):592-5. PubMed ID: 20970277
[TBL] [Abstract][Full Text] [Related]
18. Preventing blood transfusion failures: FMEA, an effective assessment method.
Najafpour Z; Hasoumi M; Behzadi F; Mohamadi E; Jafary M; Saeedi M
BMC Health Serv Res; 2017 Jun; 17(1):453. PubMed ID: 28666439
[TBL] [Abstract][Full Text] [Related]
19. Failure mode and effects analysis: A community practice perspective.
Schuller BW; Burns A; Ceilley EA; King A; LeTourneau J; Markovic A; Sterkel L; Taplin B; Wanner J; Albert JM
J Appl Clin Med Phys; 2017 Nov; 18(6):258-267. PubMed ID: 28944980
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of STAT RAD: Improvement of a novel rapid tomotherapy-based radiation therapy workflow by failure mode and effects analysis.
Jones RT; Handsfield L; Read PW; Wilson DD; Van Ausdal R; Schlesinger DJ; Siebers JV; Chen Q
Pract Radiat Oncol; 2015; 5(2):106-12. PubMed ID: 25413416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
